Molecular DiagnosticsInfectious Disease Testing Market
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics in Infectious Disease Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics in Infectious Disease Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics in Infectious Disease Testing Overall Market Size
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size: 2021 VS 2028
2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics in Infectious Disease Testing Players in Global Market
3.2 Top Global Molecular Diagnostics in Infectious Disease Testing Companies Ranked by Revenue
3.3 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics in Infectious Disease Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Molecular Diagnostics in Infectious Disease Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics in Infectious Disease Testing Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics in Infectious Disease Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics in Infectious Disease Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Molecular Diagnostics in Infectious Disease Testing Market Size Markets, 2021 & 2028
4.1.2 Polymerase Chain Reaction (PCR)
4.1.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
4.1.4 Microarrays
4.1.5 Next-Generation Sequencing (NGS)
4.1.6 Hybridization
4.1.7 Others
4.2 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2017-2022
4.2.2 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2023-2028
4.2.3 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics in Infectious Disease Testing Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Academic Institutes
5.1.5 Laboratories
5.1.6 Others
5.2 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2017-2022
5.2.2 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2023-2028
5.2.3 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics in Infectious Disease Testing Market Size, 2021 & 2028
6.2 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2017-2022
6.2.2 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2023-2028
6.2.3 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics in Infectious Disease Testing Revenue, 2017-2028
6.3.2 US Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.3.3 Canada Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.3.4 Mexico Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics in Infectious Disease Testing Revenue, 2017-2028
6.4.2 Germany Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.4.3 France Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.4.4 U.K. Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.4.5 Italy Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.4.6 Russia Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.4.7 Nordic Countries Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.4.8 Benelux Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics in Infectious Disease Testing Revenue, 2017-2028
6.5.2 China Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.5.3 Japan Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.5.4 South Korea Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.5.5 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.5.6 India Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics in Infectious Disease Testing Revenue, 2017-2028
6.6.2 Brazil Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.6.3 Argentina Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue, 2017-2028
6.7.2 Turkey Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.7.3 Israel Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
6.7.5 UAE Molecular Diagnostics in Infectious Disease Testing Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.1.4 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 BD
7.2.1 BD Corporate Summary
7.2.2 BD Business Overview
7.2.3 BD Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.2.4 BD Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.2.5 BD Key News
7.3 BioMerieux
7.3.1 BioMerieux Corporate Summary
7.3.2 BioMerieux Business Overview
7.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.3.4 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.3.5 BioMerieux Key News
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Corporate Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.4.4 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.4.5 Thermo Fisher Scientific Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.5.4 Roche Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 Siemens
7.6.1 Siemens Corporate Summary
7.6.2 Siemens Business Overview
7.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.6.4 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.6.5 Siemens Key News
7.7 Veridex
7.7.1 Veridex Corporate Summary
7.7.2 Veridex Business Overview
7.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.7.4 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.7.5 Veridex Key News
7.8 Luminex
7.8.1 Luminex Corporate Summary
7.8.2 Luminex Business Overview
7.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.8.4 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.8.5 Luminex Key News
7.9 GenMark Diagnostics
7.9.1 GenMark Diagnostics Corporate Summary
7.9.2 GenMark Diagnostics Business Overview
7.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.9.4 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.9.5 GenMark Diagnostics Key News
7.10 Qiagen
7.10.1 Qiagen Corporate Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.10.4 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.10.5 Qiagen Key News
7.11 Genomix Biotech
7.11.1 Genomix Biotech Corporate Summary
7.11.2 Genomix Biotech Business Overview
7.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.11.4 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.11.5 Genomix Biotech Key News
7.12 BioTheranostics
7.12.1 BioTheranostics Corporate Summary
7.12.2 BioTheranostics Business Overview
7.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.12.4 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2017-2022)
7.12.5 BioTheranostics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Molecular Diagnostics in Infectious Disease Testing Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnostics in Infectious Disease Testing Market Drivers in Global Market
Table 3. Molecular Diagnostics in Infectious Disease Testing Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnostics in Infectious Disease Testing in Global Market
Table 5. Top Molecular Diagnostics in Infectious Disease Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Molecular Diagnostics in Infectious Disease Testing Product Type
Table 9. List of Global Tier 1 Molecular Diagnostics in Infectious Disease Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnostics in Infectious Disease Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Molecular Diagnostics in Infectious Disease Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Molecular Diagnostics in Infectious Disease Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Molecular Diagnostics in Infectious Disease Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Molecular Diagnostics in Infectious Disease Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 32. Abbott Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 33. BD Corporate Summary
Table 34. BD Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 35. BD Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 36. BioMerieux Corporate Summary
Table 37. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 38. BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 39. Thermo Fisher Scientific Corporate Summary
Table 40. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 41. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 44. Roche Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 45. Siemens Corporate Summary
Table 46. Siemens Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 47. Siemens Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 48. Veridex Corporate Summary
Table 49. Veridex Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 50. Veridex Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 51. Luminex Corporate Summary
Table 52. Luminex Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 53. Luminex Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 54. GenMark Diagnostics Corporate Summary
Table 55. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 56. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 57. Qiagen Corporate Summary
Table 58. Qiagen Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 59. Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 60. Genomix Biotech Corporate Summary
Table 61. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 62. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 63. BioTheranostics Corporate Summary
Table 64. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Offerings
Table 65. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Molecular Diagnostics in Infectious Disease Testing Segment by Type in 2021
Figure 2. Molecular Diagnostics in Infectious Disease Testing Segment by Application in 2021
Figure 3. Global Molecular Diagnostics in Infectious Disease Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnostics in Infectious Disease Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2021
Figure 8. By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 12. US Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 16. Germany Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 24. China Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Molecular Diagnostics in Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BD Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Siemens Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Veridex Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Luminex Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
